Alexis N. Smith: How Apolipoproteins Influence Platelet Function
Alexis N. Smith, Postdoctoral Fellow at Versiti Inc., shared on LinkedIn about a recent article she and her colleagues co-authored, published in JTH, adding:
”Excited to share that my 1st first‑author publication from my postdoc has been published as a JTH Commentary in the Journal of Thrombosis and Haemostasis.
In this commentary, we discussed a recent paper by W. C. Schrottmaier et al., ‘Elevated levels of apolipoprotein C‑III impair platelet function and reduce thrombosis,’ which highlights an unexpected role for apoC‑III beyond its well‑known links to atherosclerosis.
Their work uncovered that apoC‑III can directly inhibit platelet activation and thrombus formation, providing an important foundation for ongoing research into how apolipoproteins influence platelet function.
Many thanks to my postdoctoral mentor, Ze Zheng, for the support and guidance.”
Title: Atherogenic apolipoprotein C-III may not be as bad as we thought
Authors: Alexis N. Smith, Ziyu Zhang, Ze Zheng

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments